Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.
Diabetes Care
; 44(3): 847-849, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1000011
ABSTRACT
OBJECTIVE:
Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed. RESEARCH DESIGN ANDMETHODS:
We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose-CGM matched pairs and included patients for analysis regardless of clinical status.RESULTS:
We included 11 patients with CGM 8 on continuous insulin infusion (CII), 8 on vasopressors, 8 intubated, 4 on high-dose glucocorticoids, 6 on renal replacement therapy, and 2 with anasarca. Accuracy was 12.58% for mean and 6.3% for median absolute relative difference. CGM reduced POC testing by â¼60% for patients on CII.CONCLUSIONS:
In this real-world preliminary analysis of rtCGM during critical illness, we demonstrate early feasibility, considerable accuracy, and meaningful reduction in the frequency of POC glucose testing.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Blood Glucose
/
COVID-19
/
Intensive Care Units
Type of study:
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Diabetes Care
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS